Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
Milestone Pharmaceuticals Inc. (MIST)
Standardized SEC financial data for Milestone Pharmaceuticals Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001408443 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-151.0%
ROIC
-189.4%
Free cash flow
-$49.3M
Debt / equity
1.37×
Current ratio
8.01×
EPS (diluted)
$-0.75
Income statement
USD
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
R&D expense
$34.5M
$38.7M
$39.8M
$31.1M
$14.4M
$18.1M
SG&A expense
$10.3M
$12.4M
$15.7M
$15.9M
$16.7M
$17.3M
Operating income
-$50.7M
-$43.1M
-$59.6M
-$61.1M
Standardized from Milestone Pharmaceuticals Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.